NCT06482957Recruiting
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2100 (estimated)
- First submitted
- 12 Jun 2024
- Start date
- 1 Apr 2022
- Primary completion date
- Apr 2028
- Lead sponsor
- Vanderbilt-Ingram Cancer Center
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT06482957
What you commit to
- Study type: Observational
- Planned participants: 2100
- From 1 Apr 2022 to the primary completion date, Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patients at any age with a history of sarcoma, with or without evidence of a persistent disease
- For pediatric patients
- Parent/primary caregiver of patient
- Sibling of patient aged 8 years or older
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University/Ingram Cancer Center Coordinator of this site? Confirm its status | Nashville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.